This report provides compelling evidence for inclusion of the TANGO2 gene mutation into the comprehensive arrhythmia and cardiomyopathy genetic panels, where it is not presently included, due to the potential change in management and counseling that may have been provided to the patient and his family if it was diagnosed at initial genetic testing. Here, TANGO2 is linked to cardiomyopathy.